Delivery Order SPE2DB22D1017-SPE2DB25FYRME
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,978.98 for SUNOSI 150 mg tablets (30-count) on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters and serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Sunosi 150 mg tablets (30-count packaging) valued at $1,013.56. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion master agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,128.85 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,335.06 on August 6, 2025, for the supply of Sunosi 150 mg tablets (30-count). This is a firm fixed-price, non-set-aside contract with performance through August 7, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,695.28 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on April 23, 2025, with an ultimate completion date of April 24, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing federal contract portfolio supporting military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SUNOSI 150 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,372.38. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count) valued at $1,793.96 under a firm fixed price contract. This non-set-aside delivery order, awarded on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a standard pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Sunosi 150 mg tablets (30-count units) valued at $21,491.34 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is expected to be completed by September 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SUNOSI 75 mg tablets (30-count units) under a firm fixed-price contract valued at $4,769.02. This non-set-aside competitive award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.60 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract represents a direct procurement action under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRMEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SUNOSI 75 mg tablets (30-count) with a ceiling value of $1,792.60. This firm fixed-price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made on a non-set-aside, competitive basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal military and veteran healthcare supply chains. AmerisourceBergen Drug Corp leverages its DLA Pharmaceutical Prime Vendor Global Program contract to fulfill diverse pharmaceutical needs across the Defense Health Agency and other federal healthcare systems. The company's extensive portfolio includes brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for SUNOSI, a wakefulness-promoting medication, exemplifies the company's role in supporting military medical readiness by providing rapid access to specialized pharmaceuticals through the firm fixed-price delivery order mechanism under its overarching indefinite delivery vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/19/25 |